Fujifilm Systems Integration Selects caresyntax for OR Integration

Today FUJIFILM Medical Systems announced that the company has selected caresyntax, a pioneering developer in surgical automation, analytics software, as the supplier of Fujifilm Systems Integration using caresyntax’s proprietary operating room (OR) integration and workflow automation intelligence.

As the healthcare industry continues to respond to today’s uncertainties, Fujifilm trusts this new partnership to aid hospital operations, improve workflow efficiencies of the interventional space, and meet patient demand surges as deferred procedures are rescheduled.

“As the only vendor that offers endoscopic imaging as well as modality solutions and enterprise-wide IT products—launching the Fujifilm Systems Integration business will allow Fujifilm to capture the full clinical value chain,” says Devon Bream, MPH, FACHE, Global Vice President Endoscopy, General Manager Systems Integration, FUJIFILM Medical Systems U.S.A., Inc. “We selected caresyntax as our supplier because the team has a demonstrated history in developing data-driven integration that provides the total visibility to achieve increased workflow efficiency, patient safety, and surgical performance.”

Together Fujifilm and caresyntax will develop a systems integration solution designed specifically for image and data integration in the operating room (OR/Hybrid OR) and endoscopy suite that will connect Fujifilm’s medical image capture products and Synapse brand viewing, storage, and analytics technologies.

“Fujifilm’s vision of closing the loop between its powerful clinical informatics ecosystem and its trusted offerings at the point of care will be a resounding success that will create value for caregivers and patients,” says Dennis Kogan, Co-Founder and CEO, caresyntax. “caresyntax is excited to leverage our robust surgical automation and analytics platform to support Fujifilm in this endeavor. We strongly believe that data-driven collaborations with health systems, medical device companies, and insurers are key to managing surgical risk and promoting smarter, safer surgery; and are proud to partner with Fujifilm in pursuit of this common goal.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.